NCT04939051 2026-03-18
Obeticholic Acid for Prevention in Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
8 trialsNCT06732388 2026-03-18
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
NCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00233935 2014-09-11
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
National Cancer Institute (NCI)
Phase 1 Completed
NCT01447927 2014-07-21
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00903136 2014-01-10
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00566800 2013-09-17
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 1 Unknown